By benedetta In Urological Evidence UpdatesPosted September 29, 2016 Optimal Timing of Androgen Ablation Therapy After Biochemical Relapse in Prostate Cancer Read More
By benedetta In Urological Evidence UpdatesPosted September 29, 2016 Focal Therapy Conference For Prostate Cancer, 7-8 Dec. 2012, Montreal Canada Read More
By benedetta In Benign Prostatic Hypertrophy (BPH)Posted September 29, 2016 Photoselective vaporization of the prostate using 80-W or 120-W laser has equivalent functional outcomes but less bleeding, shorter catheterization times and shorter hospital stay than traditional TURP Read More
By benedetta In Benign Prostatic Hypertrophy (BPH)Posted September 29, 2016 Men with PSA >1.4 ng/ml and/or larger prostate sizes (>30 ml) are most likely to benefit from finasteride 5mg daily in terms of symptom and flow rate improvement Read More
By benedetta In Benign Prostatic Hypertrophy (BPH)Posted September 29, 2016 Combination dutasteride plus tamsulosin significantly improves symptom scores in men with IPSS =12, PSA =1.5-10 ng/ml, prostate volume =30 ml, flow rate 5-15 ml/sec (combAT) Read More
By benedetta In Benign Prostatic Hypertrophy (BPH)Posted September 29, 2016 Combination medical therapy with alpha blocker plus finasteride reduces clinical progression of BPH more than either drug alone, and combination or finasteride alone reduces the risk of acute urinary retention or needing surgery (MTOPS) Read More
By benedetta In Bladder CancerPosted September 29, 2016 Chemoradiation using 55-64Gy with fluorouracil and mitomycin C confers a 12% improvement in locoregional disease-free survival than radiation alone as bladder preserving primary treatment for muscle invasive bladder cancer Read More
By benedetta In Bladder CancerPosted September 29, 2016 Muscle invasive bladder cancer is best treated by radical cystectomy extended pelvic node dissection and continent ileal neobladder with consideration of either neoadjuvant or adjuvant chemotherapy in higher risk patients Read More
By benedetta In Bladder CancerPosted September 29, 2016 T1G3 bladder cancer has a high risk of progression and as such a second resection is imperative to reduce understaging and early cystectomy with ileal neobladder is safe and improves disease specific survival Read More
By benedetta In Bladder CancerPosted September 29, 2016 Non muscle invasive bladder cancer evidence based guidelines have been clearly established in terms of intravesical therapy (Canadian) Read More
